Session » Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)
-
Abstract Number: 1304
Increased Risk of Vertebral Fracture Among Patients with Psoriatic Arthritis: A Systematic Review and Meta-analysis
-
Abstract Number: 1305
Undiagnosed Depression in Axial Spondyloarthropathy and the Negative Impact on Patient Outcomes: Results of a Screening Study
-
Abstract Number: 1306
Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients
-
Abstract Number: 1307
Uveitis in Spondyloarthritis Patients. Is There Any Specific Clinical Picture?
-
Abstract Number: 1308
Higher Prevalence of Echocardiographic Abnormalities in Psoriatic Arthritis and Rheumatoid Arthritis Patients Compared to Controls
-
Abstract Number: 1309
Impact of the Number of Comorbidities on the Outcome Measures and on the Retention Rate of the First Anti-TNF in Patients with Ankylosing Spondylitis: Two-year Follow-up REGISPONSER-AS
-
Abstract Number: 1310
Clinical Characteristics of Patients with SpA and Concomitant IBD: Results from the ASAS PerSpA Study
-
Abstract Number: 1311
De Novo Psoriasis Can Be Reported at Any Timepoint in Early Axial Spondyloarthritis: An Analysis of 6 Years of Follow-up of the DESIR Cohort
-
Abstract Number: 1312
What Is the Optimal Screening Strategy for Early Recognition of Spondyloarthritis in Patients with Acute Anterior Uveitis?
-
Abstract Number: 1313
The Impact of Comorbidities on Patients with Axial Spondyloarthritis: A Cluster Analysis
-
Abstract Number: 1314
Predictive Factors for the Development Acute Anterior Uveitis Attacks in Patients with Axial Spondyloarthritis; The Results of a Longitudinal Analysis
-
Abstract Number: 1315
The Best Cardiovascular Risk Algorithm to Predict the Presence of Carotid Plaque in Psoriatic Arthritis Patients
-
Abstract Number: 1316
Vitamin D Deficiency and Disease Activity in Patients with Spondyloarthritis
-
Abstract Number: 1317
Impairment of Memory in Axial Spondyloarthritis?
-
Abstract Number: 1318
Interplay Between Covid-19 and Spondyloarthritis or Its Treatment
-
Abstract Number: 1319
Cardiovascular Risk Reclassification According to Six Traditional Cardiovascular Risk Algorithms and a Carotid Ultrasound in Psoriatic Arthritis Patients
-
Abstract Number: 1320
Obesity and Its Associations with Clinical Manifestations and Disease Burden of Patients with Spondyloarthritis: An Ancillary Study from the ASAS-perSpA Project
-
Abstract Number: 1321
Uveitis in Patients with Psoriatic Arthritis – a Database Analysis
-
Abstract Number: 1322
Body Mass Index (BMI) Underestimates Obesity in Females with Axial Spondyloarthropathy
-
Abstract Number: 1323
Uveitis in 406 Patients with Psoriatic Arthritis: Epidemiology, Clinical Characteristics and Relationship with Biological Treatment. Study of a Single University Center
-
Abstract Number: 1324
Uveitis in 301 Patients with Axial Spondyloarthritis of a Single University Center: Epidemiology, Clinical Features and Biological Treatment
-
Abstract Number: 1325
Osteoporosis in Psoriatic Arthritis
-
Abstract Number: 1326
Epidemiology of Comorbidities in an Incident Psoriasis Cohort: A Population-Based Study